Phillip Chappell

3.7k total citations
47 papers, 2.6k citations indexed

About

Phillip Chappell is a scholar working on Clinical Psychology, Psychiatry and Mental health and Experimental and Cognitive Psychology. According to data from OpenAlex, Phillip Chappell has authored 47 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Clinical Psychology, 24 papers in Psychiatry and Mental health and 9 papers in Experimental and Cognitive Psychology. Recurrent topics in Phillip Chappell's work include Obsessive-Compulsive Spectrum Disorders (16 papers), Attention Deficit Hyperactivity Disorder (14 papers) and Suicide and Self-Harm Studies (8 papers). Phillip Chappell is often cited by papers focused on Obsessive-Compulsive Spectrum Disorders (16 papers), Attention Deficit Hyperactivity Disorder (14 papers) and Suicide and Self-Harm Studies (8 papers). Phillip Chappell collaborates with scholars based in United States, Türkiye and United Kingdom. Phillip Chappell's co-authors include Lawrence David Scahill, James F. Leckman, Mark A. Riddle, Robert T. Schultz, George M. Anderson, Donald J. Cohen, Maureen T. Hardin, D J Cohen, AFT Arnsten and Liliya Katsovich and has published in prestigious journals such as JAMA, American Journal of Psychiatry and Neurology.

In The Last Decade

Phillip Chappell

46 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Phillip Chappell United States 22 1.4k 1.0k 937 445 306 47 2.6k
Nicholas C. Stefanis Greece 26 1.1k 0.8× 1.7k 1.7× 818 0.9× 333 0.7× 575 1.9× 59 3.2k
Allen D. Radant United States 28 577 0.4× 963 0.9× 1.3k 1.4× 501 1.1× 433 1.4× 46 2.9k
Peter F. Goyer United States 15 1.2k 0.9× 632 0.6× 463 0.5× 752 1.7× 352 1.2× 23 2.5k
Silvio Scarone Italy 30 1.4k 1.1× 967 1.0× 1.3k 1.4× 484 1.1× 768 2.5× 131 3.4k
E. Serap Monkul United States 31 643 0.5× 1.6k 1.6× 1.0k 1.1× 238 0.5× 476 1.6× 52 2.9k
Michael Poyurovsky Israel 35 1.6k 1.2× 1.7k 1.6× 1.1k 1.1× 403 0.9× 357 1.2× 90 3.1k
Judy Rubinsztein United Kingdom 23 563 0.4× 1.4k 1.4× 1.0k 1.1× 676 1.5× 687 2.2× 47 3.1k
Kenji W. Sax United States 27 1.1k 0.8× 2.4k 2.4× 858 0.9× 477 1.1× 408 1.3× 36 3.5k
Julio Vallejo Spain 33 2.3k 1.7× 634 0.6× 1.2k 1.3× 327 0.7× 958 3.1× 61 3.4k
Hinderk M. Emrich Germany 29 545 0.4× 567 0.6× 943 1.0× 302 0.7× 442 1.4× 76 2.2k

Countries citing papers authored by Phillip Chappell

Since Specialization
Citations

This map shows the geographic impact of Phillip Chappell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip Chappell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip Chappell more than expected).

Fields of papers citing papers by Phillip Chappell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phillip Chappell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip Chappell. The network helps show where Phillip Chappell may publish in the future.

Co-authorship network of co-authors of Phillip Chappell

This figure shows the co-authorship network connecting the top 25 collaborators of Phillip Chappell. A scholar is included among the top collaborators of Phillip Chappell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phillip Chappell. Phillip Chappell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ludwig, Lisa, Scott N. Compton, Samuel Broderick, et al.. (2025). Safety Outcomes from a Long-Term, Prospective Study of Sertraline Use in Children and Adolescents: The Sertraline Pediatric Registry for the Evaluation of Safety. Journal of Child and Adolescent Psychopharmacology. 35(6). 326–336.
2.
Compton, Scott N., Samuel Broderick, John Orazem, et al.. (2023). Effects of Long-Term Sertraline Use on Pediatric Growth and Development: The Sertraline Pediatric Registry for The Evaluation of Safety (SPRITES). Journal of Child and Adolescent Psychopharmacology. 33(1). 2–13. 5 indexed citations
3.
Findling, Robert L., et al.. (2022). Efficacy, Safety, and Tolerability of Flexibly Dosed Ziprasidone in Children and Adolescents with Mania in Bipolar I Disorder: A Randomized Placebo-Controlled Replication Study. Journal of Child and Adolescent Psychopharmacology. 32(3). 143–152. 5 indexed citations
4.
Compton, Scott N., Samuel Broderick, John Orazem, et al.. (2021). Sertraline Pediatric Registry for the Evaluation of Safety: Design and Clinical Characteristics of Pediatric Patients Prescribed Sertraline. Journal of Child and Adolescent Psychopharmacology. 31(6). 411–420. 3 indexed citations
5.
Wigal, Sharon B., et al.. (2020). Diagnosis and Treatment Options for Preschoolers with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 30(2). 104–118. 16 indexed citations
6.
Wigal, Sharon B., Ann Childress, Susan A. Berry, et al.. (2018). Optimization of Methylphenidate Extended-Release Chewable Tablet Dose in Children with ADHD: Open-Label Dose Optimization in a Laboratory Classroom Study. Journal of Child and Adolescent Psychopharmacology. 28(5). 314–321. 9 indexed citations
7.
Chappell, Phillip, Michelle Stewart, Larry Alphs, et al.. (2017). Assessment of Suicidal Ideation and Behavior. The Journal of Clinical Psychiatry. 78(6). e638–e647. 10 indexed citations
8.
Wigal, Sharon B., Ann Childress, Susan A. Berry, et al.. (2017). Efficacy and Safety of a Chewable Methylphenidate Extended-Release Tablet in Children with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 27(8). 690–699. 23 indexed citations
9.
Cannizzaro, Michael S., Brian Harel, Nicole Reilly, Phillip Chappell, & Peter J. Snyder. (2004). Voice acoustical measurement of the severity of major depression. Brain and Cognition. 56(1). 30–35. 150 indexed citations
10.
Scahill, Lawrence David, Phillip Chappell, Robert T. Schultz, et al.. (2001). A Placebo-Controlled Study of Guanfacine in the Treatment of Children With Tic Disorders and Attention Deficit Hyperactivity Disorder. American Journal of Psychiatry. 158(7). 1067–1074. 423 indexed citations
11.
Duncan, Erica, Elsa J. Bartlett, Steven Madonick, et al.. (2000). Impaired prepulse inhibition of acoustic startle in schizophrenia. Biological Psychiatry. 47(7). 662–669. 197 indexed citations
12.
Sallee, Floyd R., Roger Kurlan, Christopher G. Goetz, et al.. (2000). Ziprasidone Treatment of Children and Adolescents With Tourette's Syndrome: A Pilot Study. Journal of the American Academy of Child & Adolescent Psychiatry. 39(3). 292–299. 245 indexed citations
13.
Wattum, Pieter Joost van, Phillip Chappell, Daniel Zelterman, Lawrence David Scahill, & James F. Leckman. (2000). Patterns of response to acute naloxone infusion in Tourette's syndrome. Movement Disorders. 15(6). 1252–1254. 21 indexed citations
14.
Kirwin, Paul D., George M. Anderson, Phillip Chappell, et al.. (1997). Assessment of diurnal variation of cerebrospinal fluid tryptophan and 5-hydroxyindoleacetic acid in healthy human females. Life Sciences. 60(12). 899–907. 14 indexed citations
15.
Leckman, James F., Wayne K. Goodman, George M. Anderson, et al.. (1995). Cerebrospinal Fluid Biogenic Amines in Obsessive Compulsive Disorder, Tourette's Syndrome, and Healthy Controls. Neuropsychopharmacology. 12(1). 73–86. 127 indexed citations
16.
Chappell, Phillip, Mark A. Riddle, George M. Anderson, et al.. (1994). Enhanced stress responsivity of tourette syndrome patients undergoing lumbar puncture. Biological Psychiatry. 36(1). 35–43. 75 indexed citations
17.
Chappell, Phillip, Maureen McSwiggan-Hardin, Lawrence David Scahill, et al.. (1994). Videotape Tic Counts in the Assessment of Tourette's Syndrome: Stability, Reliability, and Validity. Journal of the American Academy of Child & Adolescent Psychiatry. 33(3). 386–393. 40 indexed citations
18.
Riddle, Mark A., Robert A. King, Maureen T. Hardin, et al.. (1990). Behavioral Side Effects of Fluoxetine in Children and Adolescents. Journal of Child and Adolescent Psychopharmacology. 1(3). 193–198. 87 indexed citations
19.
Smith, Mark A., Jonathan Davidson, James Ritchie, et al.. (1989). The corticotropin-releasing hormone test in patients with posttraumatic stress disorder. Biological Psychiatry. 26(4). 349–355. 183 indexed citations
20.
Leckman, James F., Mark A. Riddle, Wade H. Berrettini, et al.. (1988). Elevated CSF dynorphin A [1–8] in Tourette's syndrome. Life Sciences. 43(24). 2015–2023. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026